
  
    
      
        Introduction_NNP
        
        c-fos_JJ is_VBZ a_DT member_NN of_IN the_DT family_NN of_IN
        immediate_JJ early_JJ genes_NNS ,_, and_CC its_PRP$ transcription_NN is_VBZ transiently_RB
        induced_VBN in_IN response_NN to_TO mitogenic_JJ signals_NNS [_NN 1_CD ]_NN ._. The_DT serum_NN
        response_NN element_NN (_( SRE_NNP )_) is_VBZ located_VBN approximately_RB 300_CD bp_NN
        upstream_RB of_IN the_DT transcriptional_NN start_NN site_NN in_IN the_DT 
        c-fos_JJ promoter_NN and_CC is_VBZ necessary_JJ for_IN
        serum_NN induction_NN of_IN 
        c-fos_JJ [_NN 2_CD ]_NN ._. The_DT SRE_NNP binds_NNS a_DT
        transcription_NN factor_NN named_VBD serum_NN response_NN factor_NN (_( SRF_NNP )_)
        which_WDT was_VBD found_VBN to_TO be_VB necessary_JJ ,_, but_CC not_RB sufficient_JJ ,_, for_IN
        serum_NN induction_NN of_IN the_DT SRE_NNP [_NN 3_CD ,_, 4_CD ,_, 5_CD ]_NN ._. 
        In_IN vivo_NN footprinting_VBG analysis_NN shows_VBZ
        that_IN SRF_NNP is_VBZ constitutively_RB bound_VBN to_TO the_DT SRE_NNP in_IN both_DT
        quiescent_JJ and_CC growth_NN factor_NN stimulated_VBN cells_NNS [_NN 6_CD ]_NN ._. This_DT
        suggests_VBZ that_IN it_PRP is_VBZ the_DT transcriptional_NN activation_NN of_IN a_DT
        complex_NN of_IN SRF_NNP and_CC its_PRP$ accessory_JJ proteins_NNS that_WDT is_VBZ regulated_VBN
        rather_RB than_IN regulation_NN of_IN SRF_NNP DNA_NNP binding_JJ ._.
        The_DT ternary_JJ complex_JJ factors_NNS (_( TCFs_NNP )_) are_VBP members_NNS of_IN the_DT
        ets_NNS family_NN of_IN transcription_NN factors_NNS ._. The_DT TCF_NNP family_NN members_NNS
        Elk-_NNP 1_CD [_NN 7_CD ]_NN ,_, SAP-_NNP 1_CD [_NN 8_CD ]_NN ,_, and_CC SAP-_NNP 2_CD /_NN ERP_NNP /_NN NET_NNP [_NN 9_CD ,_, 10_CD ]_NN have_VBP
        been_VBN found_VBN to_TO have_VB a_DT role_NN in_IN regulating_VBG the_DT SRE_NNP ._. TCFs_NNP
        cannot_NN bind_NN the_DT SRE_NNP autonomously_RB ,_, but_CC require_VB
        protein-protein_JJ interactions_NNS with_IN SRF_NNP in_IN order_NN to_TO bind_NN the_DT
        SRE_NNP [_NN 11_CD ,_, 12_CD ,_, 13_CD ,_, 14_CD ,_, 15_CD ]_NN ._. The_DT TCFs_NNP contain_VB 3_CD conserved_JJ
        motifs_NNS termed_VBD the_DT A_DT ,_, B_NNP ,_, and_CC C_NNP boxes_NNS [_NN 16_CD ]_NN ._. The_DT N-_NNP terminal_NN
        A-_NNP box_NN (_( amino_JJ acids_NNS (_( aa_NN )_) 1_CD -_: 90_CD of_IN Elk-_NNP 1_LS )_) is_VBZ necessary_JJ to_TO bind_NN
        DNA_NNP ,_, while_IN the_DT central_JJ B-_NNP box_NN (_( aa_NN 148_CD -_: 168_CD )_) is_VBZ the_DT SRF_NNP
        interaction_NN domain_NN ._. The_DT C-_NNP terminal_NN C-_NNP box_NN (_( aa_NN 352_CD -_: 399_CD )_) ,_,
        harboring_VBG the_DT transactivation_NN domain_NN ,_, contains_VBZ several_JJ
        consensus_NN mitogen_NN activated_VBN protein_NN kinase_NN (_( MAPK_NNP )_)
        phosphorylation_NN sites_NNS ._. Accordingly_RB ,_, the_DT TCFs_NNP have_VBP been_VBN
        found_VBN to_TO be_VB targets_NNS of_IN the_DT Ras-_NNP Raf-_NNP MAPK_NNP signal_NN transduction_NN
        pathway_NN [_NN 16_CD ]_NN ._. In_IN addition_NN ,_, the_DT TCFs_NNP have_VBP been_VBN found_VBN to_TO be_VB
        targets_NNS for_IN all_DT three_CD families_NNS of_IN MAPKs_NNP :_: the_DT extracellular_NN
        signal-regulated_JJ kinases_NNS 1_CD /_NN 2_CD (_( ERK_NNP 1_CD /_NN 2_LS )_) ,_, the_DT jun-_NN N-_NNP terminal_NN
        kinases_NNS /_NN stress_NN activated_VBN protein_NN kinases_NNS (_( JNK_NNP /_NN SAPK_NNP )_) ,_, and_CC
        the_DT p_NN 38_CD kinase_NN [_NN 17_CD ,_, 18_CD ]_NN ._. The_DT transcriptional_NN activity_NN of_IN
        the_DT TCFs_NNP are_VBP stimulated_VBN by_IN phosphorylation_NN of_IN the_DT
        C-_NNP terminal_NN MAPK_NNP sites_NNS [_NN 16_CD ,_, 17_CD ]_NN ._.
        Another_DT transcription_NN factor_NN that_WDT is_VBZ involved_VBN in_IN
        regulation_NN of_IN the_DT 
        c-fos_JJ SRE_NNP is_VBZ CCAAT_NNP /_NN Enhancer_NNP binding_JJ
        protein-beta_JJ (_( C_NNP /_NN EBPβ_NNP )_) ._. C_NNP /_NN EBPβ_NNP (_( also_RB known_VBN as_IN NF-IL_NNP 6_CD ,_, LAP_NNP ,_,
        NF-M_NNP ,_, AGP_NNP /_NN EBP_NNP ,_, and_CC CRP_NNP 2_LS )_) is_VBZ a_DT member_NN of_IN the_DT basic-leucine_JJ
        zipper_NN family_NN of_IN transcription_NN factors_NNS [_NN 19_CD ,_, 20_CD ]_NN ._. The_DT
        C_NNP /_NN EBPβ_NNP mRNA_NN contains_VBZ three_CD in-frame_JJ methionines_NNS which_WDT give_VBP
        rise_NN to_TO three_CD different_JJ translation_NN products_NNS :_: p_NN 38_CD ,_, p_NN 35_CD ,_, and_CC
        p_NN 20_CD -_: C_NNP /_NN EBPβ_NNP [_NN 21_CD ]_NN ._. p_NN 38_CD and_CC p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP both_DT contain_VB an_DT
        N-_NNP terminal_NN transactivation_NN domain_NN and_CC a_DT C-_NNP terminal_NN DNA_NNP
        binding_JJ /_NN dimerization_NN domain_NN ._. p_NN 20_CD -_: C_NNP /_NN EBPβ_NNP lacks_VBZ the_DT
        N-_NNP terminal_NN transactivation_NN domain_NN and_CC therefore_RB acts_VBZ as_IN a_DT
        repressor_NN of_IN transcription_NN ._. Our_PRP$ lab_NN has_VBZ previously_RB shown_VBN
        that_DT p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP activates_NNS an_DT SRE-driven_NNP reporter_NN construct_VB
        while_IN p_NN 20_CD -_: C_NNP /_NN EBPβ_NNP inhibits_NNS serum_NN stimulation_NN of_IN the_DT same_JJ
        reporter_NN [_NN 22_CD ]_NN ._. We_PRP have_VBP also_RB shown_VBN that_IN both_DT p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP and_CC
        p_NN 20_CD -_: C_NNP /_NN EBPβ_NNP could_MD interact_NN with_IN SRF_NNP 
        in_IN vivo_NN and_CC that_IN the_DT interaction_NN
        between_IN SRF_NNP and_CC p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP ,_, but_CC not_RB between_IN SRF_NNP and_CC
        p_NN 20_CD -_: C_NNP /_NN EBPβ_NNP ,_, is_VBZ stimulated_VBN by_IN activated_VBN Ras_NNP ._. The_DT target_NN for_IN
        this_DT Ras_NNP stimulation_NN is_VBZ Thr_NNP 235_CD in_IN a_DT consensus_NN MAPK_NNP site_NN in_IN
        C_NNP /_NN EBPβ_NNP [_NN 23_CD ]_NN ._. Therefore_RB ,_, C_NNP /_NN EBPβ_NNP is_VBZ a_DT target_NN of_IN a_DT
        Ras-dependent_NNP signaling_VBG pathway_NN that_WDT regulates_VBZ its_PRP$
        interaction_NN with_IN SRF_NNP ._.
        Based_VBN on_IN the_DT observations_NNS that_IN TCF_NNP factors_NNS as_RB well_RB as_IN
        p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP :_: (_( 1_LS )_) interact_NN with_IN SRF_NNP (_( 2_LS )_) transactivate_NN the_DT SRE_NNP
        and_CC (_( 3_LS )_) are_VBP responsive_JJ to_TO Ras-dependent_NNP signaling_VBG pathways_NNS ,_,
        we_PRP tested_VBD the_DT possibility_NN that_IN both_DT TCF_NNP and_CC p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP are_VBP
        necessary_JJ for_IN maximal_NN induction_NN of_IN the_DT SRE_NNP in_IN response_NN to_TO
        mitogenic_JJ stimulation_NN ._. In_IN this_DT study_NN ,_, we_PRP show_VBP that_DT
        p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP and_CC the_DT TCF_NNP family_NN member_NN Elk-_NNP 1_CD synergize_NN in_IN
        transactivation_NN of_IN SRF_NNP dependent_JJ transcription_NN of_IN both_DT a_DT
        Gal_NNP 4_CD dependent_JJ reporter_NN and_CC an_DT SRE-driven_NNP reporter_NN
        construct_VB ,_, but_CC only_RB in_IN response_NN to_TO mitogenic_JJ stimulation_NN by_IN
        Ras_NNP ._. We_PRP further_JJ show_NN that_IN Elk-_NNP 1_CD and_CC p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP interact_NN 
        in_IN vitro_NN in_IN a_DT
        glutathione-_NN S-_NNP transferase_NN (_( GST_NNP )_) -_: pulldown_NN assay_NN as_RB well_RB as_IN
        in_IN an_DT 
        in_IN vivo_NN coimmunoprecipitation_NN assay_NN ._.
        The_DT 
        in_IN vivo_NN interaction_NN is_VBZ dependent_JJ on_IN
        the_DT presence_NN of_IN activated_VBN Ras_NNP ._. Finally_RB ,_, we_PRP show_VBP that_IN the_DT
        C-_NNP terminal_NN domain_NN of_IN C_NNP /_NN EBPβ_NNP is_VBZ sufficient_JJ to_TO interact_NN with_IN
        Elk-_NNP 1_CD while_IN the_DT N-_NNP terminal_NN A-_NNP box_NN of_IN Elk-_NNP 1_CD is_VBZ necessary_JJ to_TO
        interact_NN with_IN C_NNP /_NN EBPβ_NNP ._. These_DT results_NNS suggest_VBP a_DT cooperative_JJ
        role_NN between_IN the_DT TCF_NNP and_CC C_NNP /_NN EBPβ_NNP transcription_NN factors_NNS in_IN
        regulation_NN of_IN the_DT 
        c-fos_JJ SRE_NNP in_IN response_NN to_TO
        Ras-dependent_NNP signaling_VBG pathways_NNS ._.
      
      
        Results_NNS
        
          Elk-_NNP 1_CD and_CC p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP synergize_NN in_IN transactivation_NN
          of_IN a_DT GAL_NNP 4_CD dependent_JJ reporter_NN
          Due_JJ to_TO the_DT common_JJ observations_NNS that_IN both_DT Elk-_NNP 1_CD and_CC
          p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP transactivate_NN the_DT SRE_NNP ,_, interact_NN with_IN SRF_NNP ,_, and_CC
          are_VBP responsive_JJ to_TO Ras-dependent_NNP signaling_VBG pathways_NNS ,_, we_PRP
          hypothesized_VBN that_IN Elk-_NNP 1_CD and_CC p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP may_MD both_DT be_VB
          necessary_JJ for_IN maximal_NN induction_NN of_IN SRF_NNP dependent_JJ
          transcription_NN ._. To_TO begin_VB to_TO test_VB this_DT hypothesis_NNS ,_, we_PRP used_VBD
          a_DT GAL_NNP 4_CD dependent_JJ reporter_NN construct_VB ,_, in_IN which_WDT a_DT CAT_NNP
          reporter_NN gene_NN is_VBZ driven_VBN by_IN five_CD copies_NNS of_IN a_DT GAL_NNP 4_CD binding_JJ
          site_NN upstream_RB of_IN the_DT adenovirus_JJ E_NN 1_CD B_NNP minimal_JJ promoter_NN
          (_( pG_NN 5_CD CAT_NNP )_) ._. We_PRP constructed_VBN a_DT GAL_NNP 4_CD DNA_NNP binding_JJ domain-_NN SRF_NNP
          fusion_NN protein_NN ,_, as_IN has_VBZ been_VBN described_VBN previously_RB [_NN 23_CD ]_NN ._.
          GAL_NNP 4_CD -_: SRF_NNP binds_NNS to_TO the_DT GAL_NNP 4_CD reporter_NN construct_VB ,_, thereby_RB
          making_VBG transcription_NN of_IN the_DT reporter_NN gene_NN dependent_JJ on_IN
          the_DT presence_NN of_IN SRF_NNP ._. As_IN shown_VBN in_IN Fig_NNP ._. 1_LS ,_, when_WRB a_DT GAL_NNP 4_CD -_: SRF_NNP
          fusion_NN construct_VB is_VBZ transfected_JJ with_IN the_DT reporter_NN ,_, there_EX
          is_VBZ no_DT increase_NN in_IN CAT_NNP activity_NN ._. The_DT SRF_NNP transactivation_NN
          domain_NN is_VBZ weak_JJ ,_, as_IN has_VBZ been_VBN shown_VBN previously_RB [_NN 24_CD ]_NN ._. When_WRB
          CMV-Elk-_NNP 1_CD is_VBZ cotransfected_JJ with_IN the_DT reporter_NN and_CC
          GAL_NNP 4_CD -_: SRF_NNP ,_, there_EX is_VBZ little_JJ increase_NN in_IN CAT_NNP activity_NN in_IN the_DT
          absence_NN of_IN activated_VBN Ras_NNP (_( CMV-Ras_NNP ._. V_NNP 12_CD )_) ._. This_DT result_NN is_VBZ
          expected_VBN since_IN the_DT transactivation_NN domain_NN of_IN Elk-_NNP 1_CD is_VBZ
          activated_VBN in_IN response_NN to_TO Ras_NNP ._. Therefore_RB ,_, when_WRB activated_VBN
          Ras_NNP is_VBZ transfected_JJ with_IN Elk-_NNP 1_CD ,_, GAL_NNP 4_CD -_: SRF_NNP ,_, and_CC the_DT
          reporter_NN ,_, the_DT CAT_NNP activity_NN increases_NNS to_TO 8_CD -_: fold_VB over_IN basal_NN
          levels_NNS ._. We_PRP cannot_NN determine_VB if_IN the_DT increase_NN in_IN CAT_NNP
          activity_NN in_IN the_DT presence_NN of_IN Ras_NNP also_RB reflects_VBZ a_DT
          stimulation_NN of_IN the_DT interaction_NN of_IN the_DT Elk-_NNP 1_CD and_CC SRF_NNP
          proteins_NNS ._.
          When_WRB CMV-LAP_NNP (_( which_WDT encodes_NNS p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP )_) is_VBZ transfected_JJ
          with_IN GAL_NNP 4_CD -_: SRF_NNP and_CC the_DT reporter_NN construct_VB ,_, we_PRP see_VBP a_DT 7_CD -_: fold_VB
          increase_NN in_IN CAT_NNP activity_NN that_WDT is_VBZ potentiated_JJ to_TO 75_CD -_: fold_VB
          when_WRB activated_VBN Ras_NNP is_VBZ cotransfected_JJ ._. Therefore_RB ,_, C_NNP /_NN EBPβ_NNP
          results_NNS in_IN a_DT much_RB larger_JJR increase_NN in_IN transcription_NN than_IN
          Elk-_NNP 1_CD ._. We_PRP have_VBP previously_RB shown_VBN that_IN Ras_NNP does_VBZ not_RB
          activate_VBP the_DT transactivation_NN domain_NN of_IN p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP [_NN 23_CD ]_NN ._.
          Thus_RB ,_, the_DT increase_NN in_IN transcription_NN in_IN this_DT assay_NN is_VBZ due_JJ
          to_TO Ras_NNP stimulation_NN of_IN the_DT SRF-p_NNP 35_CD -_: C_NNP /_NN EBPβ_NNP interaction_NN ._.
          Interestingly_RB ,_, when_WRB all_DT three_CD constructs_NNS -_: SRF_NNP ,_, Elk-_NNP 1_CD ,_,
          and_CC p_NN 35_CD -_: C_NNP /_NN EBPβ-are_NNP cotransfected_JJ with_IN the_DT reporter_NN
          construct_VB ,_, there_EX is_VBZ an_DT average_JJ 260_CD -_: fold_VB increase_NN in_IN CAT_NNP
          activity_NN in_IN the_DT presence_NN of_IN activated_VBN Ras_NNP ._. The_DT values_NNS of_IN
          fold_VB activation_NN varied_VBD from_IN as_RB low_JJ as_IN 60_CD -_: fold_VB to_TO as_RB high_JJ
          as_IN 725_CD -_: fold_VB over_IN basal_NN levels_NNS ,_, and_CC we_PRP are_VBP unsure_JJ of_IN the_DT
          reason_NN for_IN this_DT variability_NN ._. However_RB ,_, regardless_RB of_IN the_DT
          extent_NN of_IN activation_NN ,_, in_IN every_DT experiment_NN there_EX was_VBD a_DT
          synergy_NN observed_VBD when_WRB both_DT Elk-_NNP 1_CD and_CC p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP are_VBP
          transfected_JJ in_IN the_DT presence_NN of_IN Ras_NNP ._. There_EX is_VBZ only_RB a_DT
          slight_JJ increase_NN in_IN CAT_NNP activity_NN in_IN the_DT absence_NN of_IN Ras_NNP ._.
          Therefore_RB ,_, Elk-_NNP 1_CD and_CC p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP are_VBP working_VBG
          synergistically_RB to_TO transactivate_NN the_DT reporter_NN construct_VB
          in_IN the_DT presence_NN of_IN SRF_NNP ._. This_DT synergism_NN is_VBZ only_RB observed_VBN
          in_IN response_NN to_TO activation_NN of_IN mitogenic_JJ signaling_VBG pathways_NNS
          by_IN Ras_NNP ._.
        
        
          Elk-_NNP 1_CD and_CC p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP synergize_NN in_IN transactivation_NN
          of_IN the_DT SRE_NNP
          Since_IN Elk-_NNP 1_CD and_CC p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP synergize_NN in_IN
          transactivation_NN of_IN SRF-dependent_NNP transcription_NN using_VBG a_DT
          GAL_NNP 4_CD -_: dependent_JJ promoter_NN ,_, we_PRP next_RB tested_VBN if_IN Elk-_NNP 1_CD and_CC
          p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP could_MD also_RB synergize_NN in_IN transactivation_NN of_IN a_DT
          native_JJ SRF_NNP binding_JJ site_NN ,_, namely_RB the_DT 
          c-fos_JJ SRE_NNP ._. To_TO test_VB this_DT
          possibility_NN ,_, NIH_NNP 3_CD T_NN 3_CD cells_NNS were_VBD transiently_RB transfected_JJ
          with_IN a_DT CAT_NNP reporter_NN gene_NN driven_VBN by_IN one_CD copy_NN of_IN the_DT wild_JJ
          type_NN SRE_NNP upstream_RB of_IN the_DT Rous_NNP sarcoma_NN virus_NN long_JJ terminal_NN
          repeat_NN minimal_JJ promoter_NN ._. As_IN shown_VBN in_IN Fig_NNP ._. 2_LS ,_, when_WRB
          p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP is_VBZ co-transfected_JJ with_IN the_DT reporter_NN construct_VB ,_,
          there_EX is_VBZ a_DT 13_CD -_: fold_VB increase_NN in_IN CAT_NNP activity_NN in_IN the_DT
          absence_NN of_IN activated_VBN Ras_NNP that_WDT is_VBZ increased_VBN to_TO 24_CD -_: fold_VB
          when_WRB CMV-Ras_NNP ._. V_NNP 12_CD is_VBZ co-transfected_JJ ._.
          When_WRB CMV-Elk-_NNP 1_CD is_VBZ co-transfected_JJ with_IN the_DT SRE_NNP reporter_NN
          construct_VB ,_, there_EX is_VBZ no_DT additional_JJ stimulation_NN in_IN
          transactivation_NN in_IN either_DT the_DT absence_NN or_CC presence_NN of_IN Ras_NNP
          compared_VBD to_TO the_DT reporter_NN alone_RB ._. However_RB ,_, when_WRB both_DT Elk-_NNP 1_CD
          and_CC p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP are_VBP transfected_JJ with_IN the_DT SRE_NNP reporter_NN
          construct_VB ,_, there_EX is_VBZ a_DT synergistic_JJ effect_NN in_IN
          transactivation_NN of_IN the_DT SRE_NNP ,_, with_IN a_DT 72_CD -_: fold_VB increase_NN in_IN
          CAT_NNP activity_NN over_IN reporter_NN construct_VB alone_RB ._. As_IN was_VBD seen_VBN
          with_IN the_DT Gal_NNP 4_CD reporter_NN ,_, this_DT synergism_NN is_VBZ only_RB observed_VBN
          in_IN the_DT presence_NN of_IN activated_VBN Ras_NNP ._. These_DT data_NNS suggest_VBP that_IN
          both_DT Elk-_NNP 1_CD and_CC p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP are_VBP necessary_JJ for_IN maximal_NN
          Ras-stimulated_NNP transactivation_NN of_IN the_DT SRE_NNP ._.
        
        
          The_DT TCF_NNP family_NN member_NN Elk-_NNP 1_CD and_CC C_NNP /_NN EBPβ_NNP interact_NN in_IN
          vitro_NN
          We_PRP next_RB tested_VBD the_DT possibility_NN that_IN there_EX could_MD be_VB a_DT
          direct_JJ protein-protein_JJ interaction_NN between_IN Elk-_NNP 1_CD and_CC
          p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP based_VBN on_IN the_DT fact_NN that_IN they_PRP synergize_NN in_IN
          transactivation_NN of_IN the_DT SRE_NNP ._. Therefore_RB ,_, we_PRP used_VBD a_DT
          GST-pulldown_NNP assay_NN to_TO determine_VB if_IN the_DT proteins_NNS could_MD
          interact_NN 
          in_IN vitro_NN ._. p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP was_VBD expressed_VBN
          as_IN a_DT chimeric_JJ GST_NNP protein_NN and_CC immobilized_JJ on_IN
          glutathione-agarose_JJ beads_NNS ._. Beads_NNP containing_VBG
          GST-p_NNP 35_CD -_: C_NNP /_NN EBPβ_NNP or_CC GST_NNP alone_RB were_VBD incubated_JJ with_IN 
          in_IN vitro_NN -_: translated_VBN Elk-_NNP 1_CD labeled_VBN
          with_IN [_NN 35_CD S_NNP ]_NN methionine_NN ._. As_IN shown_VBN in_IN Fig_NNP ._. 3_LS ,_, lane_NN 2_CD ,_,
          approximately_RB 35_CD -_: 45_CD %_NN of_IN the_DT input_NN Elk-_NNP 1_CD was_VBD retained_VBN on_IN
          the_DT GST-p_NNP 35_CD -_: C_NNP /_NN EBPβ_NNP beads_NNS ._. A_DT small_JJ amount_NN of_IN Elk-_NNP 1_CD bound_VBN
          to_TO the_DT beads_NNS containing_VBG GST_NNP alone_RB (_( Fig_NNP ._. 3_LS ,_, lane_NN 3_LS )_) which_WDT
          we_PRP have_VBP been_VBN unable_JJ to_TO eliminate_VB even_RB after_IN blocking_VBG with_IN
          unprogrammed_JJ translation_NN lysate_NN ._. However_RB ,_, it_PRP is_VBZ clear_JJ
          that_IN the_DT binding_JJ of_IN Elk-_NNP 1_CD is_VBZ substantially_RB increased_VBN when_WRB
          the_DT GST-p_NNP 35_CD -_: C_NNP /_NN EBPβ_NNP fusion_NN protein_NN is_VBZ present_JJ on_IN the_DT
          beads_NNS ._. These_DT data_NNS indicate_VBP that_IN Elk-_NNP 1_CD and_CC p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP are_VBP
          capable_JJ of_IN interacting_VBG 
          in_IN vitro_NN ._.
        
        
          Elk-_NNP 1_CD and_CC p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP interact_NN in_IN vivo_NN ,_, but_CC only_RB in_IN
          the_DT presence_NN of_IN activated_VBN Ras_NNP
          Since_IN we_PRP observed_VBD an_DT 
          in_IN vitro_NN interaction_NN between_IN the_DT
          Elk-_NNP 1_CD and_CC C_NNP /_NN EBPβ_NNP proteins_NNS ,_, we_PRP next_RB tested_VBN whether_IN the_DT
          proteins_NNS could_MD interact_NN 
          in_IN vivo_NN as_RB well_RB ._. To_TO do_VB this_DT ,_, we_PRP
          used_VBD a_DT co-immunoprecipitation_JJ approach_NN ._. COS-_NNP 7_CD cells_NNS were_VBD
          transfected_JJ with_IN an_DT expression_NN vector_NN for_IN a_DT 6_CD X_NNP histidine_NN
          tagged_VBN construct_VB of_IN p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP carrying_VBG the_DT φ_NN 10_CD (_( T_NN 7_CD tag_NN )_)
          epitope_NN sequence_NN either_CC in_IN the_DT presence_NN or_CC absence_NN of_IN
          Elk-_NNP 1_CD ._. Cell_NNP lysates_NNS were_VBD incubated_JJ with_IN T_NN 7_CD tag_NN Ab_NNP agarose_NN
          beads_NNS followed_VBN by_IN immunoblotting_VBG of_IN the_DT precipitated_VBD
          proteins_NNS with_IN Elk-_NNP 1_CD Ab_NNP ._. As_IN shown_VBN in_IN Fig_NNP ._. 4_LS ,_, there_EX is_VBZ no_DT
          Elk-_NNP 1_CD protein_NN precipitated_VBD with_IN the_DT tagged_VBN C_NNP /_NN EBPβ_NNP protein_NN
          when_WRB both_DT are_VBP transfected_JJ (_( lane_NN 5_LS )_) ._. However_RB ,_, since_IN the_DT
          synergism_NN of_IN Elk-_NNP 1_CD and_CC p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP is_VBZ observed_VBN when_WRB
          activated_VBN Ras_NNP is_VBZ present_JJ ,_, we_PRP thought_VBD it_PRP likely_JJ that_IN the_DT
          interaction_NN between_IN the_DT two_CD proteins_NNS could_MD be_VB
          Ras-dependent_NNP ._. Indeed_RB ,_, when_WRB activated_VBN Ras_NNP is_VBZ
          co-transfected_JJ along_IN with_IN Elk-_NNP 1_CD and_CC histidine-tagged_JJ
          p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP ,_, the_DT Elk-_NNP 1_CD protein_NN is_VBZ precipitated_VBD with_IN the_DT
          p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP (_( lane_NN 6_CD )_) ._. One_CD possible_JJ explanation_NN for_IN this_DT
          result_NN is_VBZ that_IN Ras_NNP increases_VBZ the_DT amount_NN of_IN p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP or_CC
          Elk-_NNP 1_CD protein_NN in_IN the_DT COS-_NNP 7_CD cells_NNS ,_, but_CC Western_JJ blot_NN
          analysis_NN showed_VBD that_IN both_DT p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP and_CC Elk-_NNP 1_CD protein_NN
          levels_NNS are_VBP the_DT same_JJ in_IN the_DT absence_NN and_CC presence_NN of_IN Ras_NNP
          (_( data_NNS not_RB shown_VBN )_) ._. Therefore_RB ,_, p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP and_CC Elk-_NNP 1_CD
          interact_NN in_IN 
          vivo_NN ,_, but_CC only_RB in_IN response_NN to_TO
          activation_NN of_IN Ras-dependent_NNP signaling_VBG pathways_NNS ._.
        
        
          The_DT C-_NNP terminal_NN domain_NN of_IN C_NNP /_NN EBPβ_NNP is_VBZ necessary_JJ to_TO
          interact_NN with_IN Elk-_NNP 1_CD in_IN vitro_NN
          Since_IN C_NNP /_NN EBPβ_NNP and_CC Elk-_NNP 1_CD interact_NN ,_, we_PRP next_RB wanted_VBD to_TO
          narrow_VB down_RP the_DT domains_NNS of_IN the_DT proteins_NNS that_WDT are_VBP required_VBN
          for_IN their_PRP$ interaction_NN ._. To_TO determine_VB the_DT domain_NN of_IN C_NNP /_NN EBPβ_NNP
          that_WDT is_VBZ necessary_JJ to_TO interact_NN with_IN Elk-_NNP 1_CD ,_, a_DT
          p_NN 20_CD -_: C_NNP /_NN EBPβ-GST_NNP fusion_NN protein_NN was_VBD constructed_VBN ._. p_NN 20_CD -_: C_NNP /_NN EBPβ_NNP
          encodes_NNS the_DT 20_CD kDa_NN form_NN of_IN C_NNP /_NN EBPβ_NNP ,_, which_WDT lacks_VBZ the_DT
          N-_NNP terminal_NN transactivation_NN domain_NN of_IN the_DT longer_JJR
          p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP isoform_NN ._. This_DT isoform_NN ,_, however_RB ,_, shares_VBZ the_DT
          C-_NNP terminal_NN DNA_NNP binding_JJ and_CC dimerization_NN domain_NN with_IN
          p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP ._. As_IN shown_VBN in_IN Fig_NNP ._. 5_LS ,_, approximately_RB the_DT same_JJ
          amount_NN of_IN [_NN 35_CD S_NNP ]_NN -_: labeled_VBN Elk-_NNP 1_CD is_VBZ retained_VBN on_IN both_DT the_DT
          GST-p_NNP 20_CD -_: C_NNP /_NN EBPβ_NNP and_CC GST-p_NNP 35_CD -_: C_NNP /_NN EBPβ_NNP beads_NNS (_( compare_VB lanes_NNS 2_CD
          and_CC 3_LS )_) ._. Therefore_RB ,_, deletion_NN of_IN the_DT N-_NNP terminus_JJ of_IN C_NNP /_NN EBPβ_NNP
          has_VBZ no_DT effect_NN on_IN its_PRP$ ability_NN to_TO interact_NN with_IN Elk-_NNP 1_CD ._. This_DT
          data_NNS demonstrates_VBZ that_IN the_DT C-_NNP terminal_NN region_NN of_IN C_NNP /_NN EBPβ_NNP is_VBZ
          sufficient_JJ to_TO mediate_VB interaction_NN with_IN Elk-_NNP 1_CD 
          in_IN vitro_NN ._.
        
        
          The_DT N-_NNP terminal_NN A-_NNP box_NN of_IN Elk-_NNP 1_CD is_VBZ sufficient_JJ to_TO
          interact_NN with_IN C_NNP /_NN EBPβ_NNP in_IN vitro_NN
          In_IN order_NN to_TO narrow_VB down_RP the_DT domain_NN of_IN Elk-_NNP 1_CD that_WDT is_VBZ
          necessary_JJ to_TO interact_NN with_IN C_NNP /_NN EBPβ_NNP 
          in_IN vitro_NN ,_, we_PRP made_VBD several_JJ Elk-_NNP 1_CD
          deletion_NN mutants_NNS (_( Fig_NNP ._. 6_CD A_DT )_) and_CC tested_VBD these_DT constructs_NNS in_IN
          a_DT pulldown_NN assay_NN with_IN GST-p_NNP 35_CD -_: C_NNP /_NN EBPβ_NNP ._. Elk-_NNP 1_CD (_( 1_CD -_: 209_CD )_) is_VBZ a_DT
          C-_NNP terminal_NN deletion_NN mutant_JJ that_WDT lacks_VBZ the_DT C-_NNP box_NN ._.
          Elk-_NNP 1_CD (_( 1_CD -_: 140_CD )_) is_VBZ also_RB a_DT C-_NNP terminal_NN deletion_NN ,_, but_CC it_PRP lacks_VBZ
          both_DT the_DT B-_NNP and_CC C-_NNP boxes_NNS ._. Therefore_RB ,_, this_DT mutant_JJ contains_VBZ
          neither_DT a_DT transactivation_NN domain_NN nor_CC an_DT SRF_NNP binding_JJ
          domain_NN ._. Finally_RB ,_, Elk-_NNP 1_CD (_( 89_CD -_: 428_CD )_) is_VBZ a_DT deletion_NN of_IN the_DT
          N-_NNP terminal_NN A-_NNP box_NN ._. Glutathione_NNP agarose_NN beads_NNS containing_VBG
          GST-p_NNP 35_CD -_: C_NNP /_NN EBPβ_NNP or_CC GST_NNP alone_RB were_VBD incubated_JJ with_IN 
          in_IN vitro_NN -_: translated_VBN Elk-_NNP 1_CD mutants_NNS
          labeled_VBN with_IN [_NN 35_CD S_NNP ]_NN methionine_NN ._. As_IN shown_VBN in_IN Fig_NNP ._. 6_CD B_NNP ,_, the_DT
          C-_NNP terminal_NN Elk-_NNP 1_CD mutants_NNS ,_, Elk-_NNP 1_CD (_( 1_CD -_: 209_CD )_) and_CC Elk-_NNP 1_CD (_( 1_CD -_: 140_CD )_) ,_,
          bound_VBN to_TO the_DT GST-p_NNP 35_CD -_: C_NNP /_NN EBPβ_NNP beads_NNS to_TO the_DT same_JJ extent_NN as_IN
          wild-type_JJ Elk-_NNP 1_CD (_( compare_VB lane_NN 3_CD of_IN top_JJ 3_CD panels_NNS )_) ._.
          However_RB ,_, the_DT A-_NNP box_NN deletion_NN mutant_JJ ,_, Elk-_NNP 1_CD (_( 89_CD -_: 428_CD )_) ,_, no_RB
          longer_RB binds_NNS to_TO the_DT GST-p_NNP 35_CD -_: C_NNP /_NN EBPβ_NNP (_( lane_NN 3_CD ,_, bottom_JJ
          panel_NN )_) ._. Therefore_RB ,_, this_DT data_NNS demonstrates_VBZ that_IN the_DT A-_NNP box_NN
          of_IN Elk-_NNP 1_CD is_VBZ necessary_JJ to_TO interact_NN with_IN C_NNP /_NN EBPβ_NNP 
          in_IN vitro_NN ._.
        
      
      
        Discussion_NNP
        We_PRP have_VBP shown_VBN that_IN the_DT transcription_NN factors_NNS Elk-_NNP 1_CD and_CC
        p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP synergize_NN in_IN transactivation_NN of_IN SRF-dependent_NNP
        transcription_NN using_VBG both_DT GAL_NNP 4_CD and_CC SRE-driven_NNP reporter_NN
        constructs_NNS ._. Interestingly_RB ,_, this_DT synergy_NN is_VBZ only_RB observed_VBN in_IN
        response_NN to_TO mitogenic_JJ stimulation_NN by_IN Ras_NNP ._. We_PRP have_VBP also_RB
        demonstrated_VBN that_IN the_DT Elk-_NNP 1_CD and_CC p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP proteins_NNS
        interact_NN using_VBG both_DT 
        in_IN vitro_NN GST-pulldown_NNP and_CC 
        in_IN vivo_NN coimmunoprecipitation_NN assays_NNS ._.
        The_DT 
        in_IN vivo_NN interaction_NN ,_, however_RB ,_, is_VBZ
        dependent_JJ on_IN the_DT presence_NN of_IN activated_VBN Ras_NNP ._. Finally_RB ,_, we_PRP
        demonstrate_VBP that_IN the_DT 
        in_IN vitro_NN interaction_NN domains_NNS of_IN the_DT
        two_CD proteins_NNS are_VBP the_DT C-_NNP terminal_NN domain_NN of_IN C_NNP /_NN EBPβ_NNP and_CC the_DT
        N-_NNP terminal_NN domain_NN of_IN Elk-_NNP 1_CD ._.
        These_DT results_NNS suggest_VBP a_DT new_JJ mechanism_NN for_IN
        transactivation_NN of_IN the_DT SRE_NNP ,_, where_WRB a_DT competent_JJ
        transcriptional_NN complex_JJ consisting_VBG of_IN at_IN least_JJS SRF_NNP ,_, TCF_NNP ,_,
        and_CC p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP participate_VB in_IN transactivation_NN in_IN response_NN
        to_TO Ras_NNP ._. To_TO this_DT point_NN ,_, the_DT TCF_NNP family_NN members_NNS have_VBP been_VBN
        thought_VBN to_TO be_VB the_DT main_JJ targets_NNS of_IN Ras_NNP signaling_VBG to_TO the_DT SRE_NNP ,_,
        and_CC activation_NN of_IN TCF_NNP by_IN Ras_NNP has_VBZ been_VBN shown_VBN to_TO result_VB in_IN
        transactivation_NN of_IN the_DT SRE_NNP [_NN 16_CD ]_NN ._. However_RB ,_, we_PRP show_VBP that_IN Ras_NNP
        activation_NN of_IN TCF_NNP alone_RB does_VBZ not_RB result_VB in_IN maximal_NN SRE_NNP
        transactivation_NN ,_, but_CC instead_RB ,_, is_VBZ greatly_RB enhanced_VBN in_IN the_DT
        presence_NN of_IN p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP ._.
        SRF_NNP and_CC TCF_NNP have_VBP been_VBN shown_VBN to_TO form_VB a_DT ternary_JJ complex_NN at_IN
        the_DT SRE_NNP 
        in_IN vitro_NN ._. We_PRP as_RB yet_RB have_VBP not_RB been_VBN
        able_JJ to_TO observe_VB a_DT ternary_JJ complex_NN between_IN SRF_NNP and_CC
        p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP at_IN the_DT SRE_NNP 
        in_IN vitro_NN ._. The_DT mechanisms_NNS of_IN SRE_NNP
        transactivation_NN described_VBD above_IN may_MD help_VB to_TO explain_VB the_DT 
        in_IN vitro_NN results_NNS ._. The_DT C_NNP /_NN EBPβ_NNP
        recognition_NN site_NN in_IN the_DT SRE_NNP is_VBZ a_DT weak_JJ binding_JJ site_NN [_NN 25_CD ]_NN ._.
        Upon_IN activation_NN of_IN Ras-dependent_NNP signaling_VBG pathways_NNS ,_, the_DT
        presence_NN of_IN p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP at_IN the_DT SRE_NNP would_MD be_VB stabilized_VBN due_JJ
        to_TO its_PRP$ strong_JJ protein-protein_JJ interactions_NNS not_RB only_RB with_IN
        SRF_NNP ,_, as_IN we_PRP have_VBP shown_VBN previously_RB [_NN 23_CD ]_NN ,_, but_CC also_RB with_IN
        Elk-_NNP 1_CD ._. It_PRP is_VBZ possible_JJ that_DT p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP and_CC SRF_NNP are_VBP not_RB
        sufficient_JJ to_TO form_VB a_DT ternary_JJ complex_NN with_IN the_DT SRE_NNP 
        in_IN vitro_NN ,_, but_CC Elk-_NNP 1_CD may_MD also_RB be_VB
        necessary_JJ ._. In_IN addition_NN ,_, it_PRP is_VBZ likely_JJ that_DT p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP ,_,
        Elk-_NNP 1_CD ,_, or_CC both_DT ,_, may_MD need_VB to_TO be_VB activated_VBN by_IN one_CD or_CC more_JJR
        MAPK_NNP family_NN members_NNS for_IN a_DT multiprotein_NN complex_JJ to_TO form_VB with_IN
        SRF_NNP at_IN the_DT SRE_NNP ._. Further_RB studies_VBZ utilizing_VBG the_DT information_NN
        from_IN the_DT 
        in_IN vivo_NN studies_NNS performed_VBN here_RB may_MD
        permit_VB us_PRP to_TO optimize_NN the_DT 
        in_IN vitro_NN conditions_NNS necessary_JJ to_TO
        observe_VB such_JJ a_DT multiprotein_NN complex_JJ ._.
        We_PRP observe_VBP a_DT direct_JJ interaction_NN between_IN C_NNP /_NN EBPβ_NNP and_CC Elk-_NNP 1_CD
        in_IN a_DT GST_NNP pulldown_NN assay_NN ._. Another_DT ets_NNS family_NN member_NN ,_, Ets-_NNP 1_CD ,_,
        has_VBZ previously_RB been_VBN shown_VBN to_TO interact_NN with_IN C_NNP /_NN EBPβ_NNP 
        in_IN vitro_NN [_NN 26_CD ]_NN ._. We_PRP have_VBP not_RB directly_RB
        tested_VBN the_DT ability_NN of_IN the_DT other_JJ TCF_NNP famlily_RB members_NNS ,_, SAP_NNP 1_CD
        and_CC SAP_NNP 2_CD /_NN ERP_NNP /_NN NET_NNP ,_, to_TO interact_NN with_IN C_NNP /_NN EBPβ_NNP ._. We_PRP find_VBP that_IN the_DT
        domain_NN of_IN Elk-_NNP 1_CD that_IN interacts_NNS with_IN C_NNP /_NN EBPβ_NNP is_VBZ the_DT ets_NNS
        domain_NN ,_, which_WDT is_VBZ conserved_JJ among_IN the_DT other_JJ TCF_NNP family_NN
        members_NNS [_NN 16_CD ]_NN ._. We_PRP would_MD therefore_RB also_RB expect_VB SAP_NNP 1_CD and_CC
        SAP_NNP 2_CD /_NN ERP_NNP /_NN NET_NNP to_TO interact_NN with_IN C_NNP /_NN EBPβ_NNP ._. Interestingly_RB ,_, the_DT 
        in_IN vivo_NN interaction_NN of_IN Elk-_NNP 1_CD and_CC
        C_NNP /_NN EBPβ_NNP is_VBZ dependent_JJ on_IN activation_NN of_IN Ras-dependent_NNP
        signaling_VBG pathways_NNS ._. The_DT target_NN (_( s_VBZ )_) of_IN the_DT Ras_NNP signaling_VBG
        pathway_NN is_VBZ as_RB yet_RB unknown_JJ ._. It_PRP has_VBZ been_VBN shown_VBN that_DT
        transfection_NN of_IN activated_VBN Ras_NNP results_NNS in_IN phosphorylation_NN of_IN
        Thr_NNP 235_CD (_( numbering_VBG for_IN human_JJ protein_NN )_) in_IN the_DT C-_NNP terminal_NN
        domain_NN of_IN C_NNP /_NN EBPβ_NNP ,_, and_CC that_IN Thr_NNP 235_CD could_MD be_VB phosphorylated_JJ
        by_IN a_DT partially_RB purified_JJ MAPK_NNP preparation_NN 
        in_IN vitro_NN [_NN 19_CD ]_NN ._. We_PRP have_VBP also_RB shown_VBN
        that_IN this_DT same_JJ residue_NN is_VBZ necessary_JJ for_IN Ras_NNP stimultion_NN of_IN
        the_DT interaction_NN between_IN C_NNP /_NN EBPβ_NNP and_CC SRF_NNP ._. Therefore_RB ,_, it_PRP will_MD
        be_VB interesting_JJ to_TO determine_VB if_IN this_DT site_NN is_VBZ also_RB critical_JJ
        for_IN stimulation_NN of_IN the_DT interaction_NN between_IN C_NNP /_NN EBPβ_NNP and_CC
        Elk-_NNP 1_CD ._. Elk-_NNP 1_CD also_RB has_VBZ several_JJ MAPK_NNP sites_NNS in_IN its_PRP$ C-_NNP terminal_NN
        domain_NN ,_, and_CC therefore_RB this_DT region_NN could_MD also_RB be_VB a_DT target_NN
        for_IN Ras_NNP ._.
        We_PRP are_VBP currently_RB investigating_VBG the_DT mechanism_NN of_IN the_DT
        observed_VBN synergy_NN between_IN Elk-_NNP 1_CD and_CC p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP ._. We_PRP have_VBP
        shown_VBN that_IN C_NNP /_NN EBPβ_NNP interacts_NNS with_IN the_DT A-_NNP box_NN of_IN Elk-_NNP 1_CD ,_, while_IN
        SRF_NNP has_VBZ previously_RB been_VBN shown_VBN to_TO interact_NN with_IN the_DT B-_NNP box_NN [_NN
        16_CD ]_NN ._. Therefore_RB ,_, C_NNP /_NN EBPβ_NNP and_CC SRF_NNP interact_NN with_IN two_CD distinct_JJ
        domains_NNS of_IN Elk-_NNP 1_CD ,_, as_RB well_RB as_IN with_IN each_DT other_JJ ,_, which_WDT could_MD
        allow_VB formation_NN of_IN a_DT complex_NN of_IN the_DT three_CD transcription_NN
        factors_NNS ._. This_DT would_MD create_VB an_DT active_JJ transcriptional_NN
        complex_JJ at_IN the_DT SRE_NNP and_CC result_NN in_IN enhanced_JJ transactivation_NN ._.
        It_PRP is_VBZ possible_JJ that_IN the_DT p_NN 35_CD -_: C_NNP /_NN EBPβ-SRF-Elk-_NNP 1_CD complex_JJ could_MD
        interact_NN more_RBR strongly_RB with_IN coactivators_NNS and_CC /_NN or_CC the_DT basal_NN
        transcriptional_NN machinery_NN than_IN each_DT individual_JJ
        transcription_NN factor_NN ._. It_PRP has_VBZ been_VBN shown_VBN that_IN SRF_NNP ,_, TCF_NNP ,_, and_CC
        C_NNP /_NN EBPβ_NNP can_MD all_DT interact_NN with_IN components_NNS of_IN transcriptional_NN
        machinery_NN such_JJ as_IN p_NN 300_CD /_NN CBP_NNP ,_, SRC-_NNP 1_CD ,_, and_CC TFII-I_NNP [_NN 27_CD ,_, 28_CD ,_, 29_CD ,_,
        30_CD ]_NN ._. There_EX is_VBZ most_RBS likely_JJ a_DT large_JJ protein_NN complex_JJ assembled_VBN
        at_IN the_DT SRE_NNP composed_VBN of_IN regulated_VBN transcription_NN factors_NNS ,_,
        coactivators_NNS ,_, and_CC the_DT basal_NN transcriptional_NN machinery_NN ,_,
        resulting_VBG in_IN rapid_JJ transcription_NN of_IN the_DT 
        c-fos_JJ gene_NN in_IN response_NN to_TO mitogenic_JJ
        stimulation_NN ._.
      
      
        Conclusions_NNP
        This_DT report_NN demonstrates_VBZ a_DT new_JJ model_NN for_IN 
        c-fos_JJ SRE_NNP activation_NN in_IN response_NN to_TO
        Ras-dependent_NNP signaling_VBG pathways_NNS ._. We_PRP show_VBP that_IN SRF_NNP ,_, Elk-_NNP 1_CD ,_,
        and_CC p_NN 35_CD -_: C_NNP /_NN EBPβ_NNP are_VBP all_DT necessary_JJ for_IN maximal_NN Ras-stimulated_NNP
        transactivation_NN of_IN the_DT SRE_NNP ._.
      
      
        Materials_NNS and_CC Methods_NNP
        
          Cell_NNP Culture_NNP and_CC Transfections_NNP
          NIH_NNP 3_CD T_NN 3_CD fibroblasts_NNS (_( from_IN the_DT American_NNP Type_NNP Culture_NNP
          Collection_NNP )_) and_CC COS-_NNP 7_CD cells_NNS (_( kindly_RB provided_VBN by_IN Dr_NNP ._. S_NNP ._.
          Hann_NNP ,_, Vanderbilt_NNP University_NNP )_) were_VBD grown_VBN in_IN Dulbecco_NNP 's_POS
          Modified_NNP Eagle_NNP Medium_NNP (_( DMEM_NNP )_) with_IN 10_CD %_NN calf_NN serum_NN
          (_( Colorado_NNP Serum_NNP Company_NNP )_) ,_, 0_CD ._. 22_CD %_NN sodium_NN bicarbonate_NN ,_, 4_CD mM_NN
          L-_NNP glutamine_NN ,_, 25_CD U_NNP of_IN penicillin_NN G_NNP sodium_NN per_IN mL_NN ,_, and_CC 25_CD
          mg_NN of_IN streptomycin_NN per_IN mL_NN ._.
          COS-_NNP 7_CD cell_NN transfections_NNS were_VBD performed_VBN by_IN the_DT calcium_NN
          phosphate_NN (_( CaPO_NNP 
          4_LS )_) technique_NN [_NN 31_CD ]_NN ._. Cells_NNP at_IN 60_CD -_: 70_CD %_NN
          confluence_NN were_VBD exposed_VBN to_TO the_DT CaPO_NNP 
          4_CD -_: DNA_NNP precipitate_NN for_IN 8_CD h_NN ._. The_DT medium_NN
          was_VBD removed_VBN and_CC replaced_VBN with_IN complete_JJ medium_NN for_IN 36_CD h_NN
          before_IN harvesting_NN ._. NIH_NNP 3_CD T_NN 3_CD transfections_NNS were_VBD performed_VBN
          using_VBG NovaFector_NNP (_( Venn_NNP Nova_NNP )_) or_CC Trans-_NNP IT_PRP LT_NNP 1_CD (_( PanVera_NNP )_) as_IN
          described_VBN by_IN the_DT manufacturers_NNS ._.
          For_IN NovaFector_NNP transfections_NNS ,_, a_DT 6_CD :_: 1_CD ratio_NN of_IN
          NovaFector_NNP :_: DNA_NNP was_VBD used_VBN for_IN each_DT transfection_NN ._. Cells_NNP at_IN
          60_CD -_: 70_CD %_NN confluence_NN were_VBD exposed_VBN to_TO the_DT NovaFector_NNP :_: DNA_NNP
          complex_JJ for_IN 6_CD -_: 7_CD h_NN in_IN serum_NN and_CC antibiotic_JJ free_JJ medium_NN ._.
          After_IN the_DT incubation_NN ,_, an_DT equal_JJ volume_NN of_IN DMEM_NNP containing_VBG
          20_CD %_NN calf_NN serum_NN was_VBD added_VBN for_IN 24_CD h_NN ,_, bringing_VBG the_DT final_JJ
          concentration_NN of_IN calf_NN serum_NN to_TO 10_CD %_NN ._. Cells_NNP were_VBD then_RB serum_NN
          deprived_VBN for_IN 36_CD -_: 40_CD h_NN in_IN DMEM_NNP supplemented_JJ as_IN above_IN except_IN
          containing_VBG 0_CD ._. 5_CD %_NN calf_NN serum_NN before_IN harvesting_NN ._. For_IN
          TransIT-LT_NNP 1_CD transfections_NNS ,_, a_DT 6_CD :_: 1_CD ratio_NN of_IN TransIT-LT_NNP 1_CD :_: DNA_NNP
          was_VBD used_VBN in_IN each_DT transfection_NN ._. Cells_NNP at_IN 60_CD -_: 70_CD %_NN confluence_NN
          were_VBD exposed_VBN to_TO the_DT TransIT-LT_NNP 1_CD :_: DNA_NNP complex_JJ for_IN 8_CD h_NN in_IN
          complete_JJ medium_NN plus_CC freshly_RB added_VBD 30_CD mg_NN /_NN mL_NN polymyxin_NN B_NNP
          antibiotic_JJ [_NN 32_CD ]_NN ._. The_DT medium_NN was_VBD then_RB removed_VBN and_CC
          replaced_VBN with_IN complete_JJ medium_NN for_IN 24_CD h_NN ._. Cells_NNP were_VBD then_RB
          serum_NN deprived_VBN in_IN DMEM_NNP containing_VBG 0_CD ._. 5_CD %_NN calf_NN serum_NN for_IN
          36_CD -_: 40_CD h_NN before_IN harvesting_NN ._. Cell_NNP extracts_NNS were_VBD prepared_VBN
          and_CC chloramphenicol_NN acetyl_NN transferase_NN (_( CAT_NNP )_) assays_NNS were_VBD
          performed_VBN on_IN extracts_NNS containing_VBG equivalent_NN cell_NN protein_NN
          as_RB previously_RB described_VBD [_NN 33_CD ]_NN ._. An_DT internal_JJ control_NN
          plasmid_NN to_TO measure_VB transfection_NN efficiency_NN could_MD not_RB be_VB
          used_VBN because_IN C_NNP /_NN EBPβ_NNP regulates_VBZ transcrption_NN from_IN the_DT
          control_NN plasmid_NN ,_, and_CC thus_RB makes_VBZ the_DT internal_JJ control_NN
          invalid_JJ ._. Therefore_RB ,_, the_DT transfections_NNS were_VBD repeated_VBN
          multiple_JJ times_NNS to_TO control_VB for_IN variability_NN in_IN transfection_NN
          efficiency_NN ._.
        
        
          Plasmids_NNP
          The_DT pGAL_NN 4_CD and_CC pG_NN 5_CD CAT_NNP plasmids_NNS were_VBD obtained_VBN from_IN the_DT
          Mammalian_NNP MATCHMAKER_NNP Two-_NNP Hybrid_NNP Assay_NNP Kit_NNP (_( CLONTECH_NNP )_) ._.
          pGAL_NN 4_CD -_: SRF_NNP was_VBD constructed_VBN as_RB previously_RB described_VBD [_NN 23_CD ]_NN ._.
          The_DT SRE-CAT_NNP reporter_NN gene_NN was_VBD constructed_VBN as_RB previously_RB
          described_VBD [_NN 22_CD ]_NN ._. pGST-p_JJ 35_CD -_: C_NNP /_NN EBPβ_NNP was_VBD constructed_VBN by_IN
          inserting_VBG the_DT 1_CD ,_, 739_CD bp_NN EcoRI_NNP fragment_NN from_IN pRSETB-EFII_JJ [_NN
          34_CD ]_NN into_IN EcoRI_NNP cut_VBD pGEX-_NN 4_CD T-_NNP 1_CD (_( Amersham-_NNP Pharmacia_NNP )_) ._.
          pGST-p_JJ 20_CD -_: C_NNP /_NN EBPβ_NNP was_VBD constructed_VBN by_IN inserting_VBG the_DT 581_CD bp_NN
          BamHI_NNP /_NN EcoRI_NNP fragment_NN from_IN pRsetA-LIP_JJ [_NN 34_CD ]_NN into_IN similarly_RB
          digested_VBN pGEX_NN 4_CD T-_NNP 1_CD ._. pcDNA_NN 3_CD /_NN Elk-_NNP 1_CD (_( 1_CD -_: 209_CD )_) and_CC
          pcDNA_NN 3_CD /_NN Elk-_NNP 1_CD (_( 1_CD -_: 140_CD )_) were_VBD constructed_VBN by_IN using_VBG the_DT
          Erase-_NNP A-B_NNP ase_NN system_NN (_( Promega_NNP )_) with_IN pcDNA_NN 3_CD /_NN Elk-_NNP 1_CD (_( gift_NN of_IN
          J_NNP ._. Schwartz_NNP ,_, Univ_NNP ._. of_IN Michigan_NNP )_) as_IN described_VBN by_IN the_DT
          manufacturer_NN ._. pcDNA_NN 3_CD ._. 1_LS /_NN His-p_NNP 35_CD -_: C_NNP /_NN EBPβ_NNP was_VBD constructed_VBN by_IN
          inserting_VBG an_DT 1_CD ,_, 739_CD bp_NN EcoRI_NNP fragment_NN from_IN pRSETB-EFII_JJ
          into_IN an_DT EcoRI_NNP cut_VBD pcDNA_NN 3_CD ._. 1_LS /_NN HisC_NNP vector_NN (_( Invitrogen_NNP )_) ._.
          CMV-LAP_NNP was_VBD a_DT gift_NN of_IN U_NNP ._. Schibler_NNP (_( Univ_NNP ._. of_IN Geneva_NNP ,_,
          Geneva_NNP ,_, Switzerland_NNP )_) and_CC CMV-Ras_NNP ._. V_NNP 12_CD was_VBD a_DT gift_NN of_IN E_NNP ._.
          Ruley_NNP (_( Vanderbilt_NNP Univ_NNP ._. )_) ._.
        
        
          Analysis_NNP of_IN ELK-_NNP 1_CD and_CC C_NNP /_NN EBPβ_NNP interaction_NN in_IN
          vitro_NN
          GST-p_NNP 35_CD -_: C_NNP /_NN EBPβ_NNP ,_, GST-p_NNP 20_CD -_: C_NNP /_NN EBPβ_NNP ,_, or_CC GST_NNP alone_RB was_VBD
          produced_VBN in_IN BL_NNP 21_CD E_NNP ._. Coli_NNP by_IN 80_CD mM_NN
          isopropyl-β-_JJ D-_NNP thiogalactopyranoside_NN (_( IPTG_NNP )_) induction_NN
          overnight_JJ at_IN 37_CD °_NN C_NNP ._. Cells_NNP were_VBD harvested_VBN by_IN centrifugation_NN
          and_CC washed_VBN once_RB with_IN phosphate-buffered_JJ saline_NN (_( PBS_NNP )_)
          containing_VBG the_DT following_NN protease_NN inhibitors_NNS :_: 2_CD mg_NN /_NN ml_NN
          aprotinin_NN ,_, 2_CD mg_NN /_NN ml_NN leupeptin_NN ,_, 2_CD mM_NN phenylmethylsulfonyl_NN
          fluoride_NN (_( PMSF_NNP )_) ,_, and_CC 0_CD ._. 2_CD mM_NN pepstatin_NN ._. The_DT bacteria_NNS were_VBD
          lysed_JJ by_IN sonication_NN at_IN 4_CD oC_NN in_IN PBS_NNP containing_VBG the_DT
          protease_NN inhibitors_NNS described_VBD above_IN ._. Triton_NNP X-_NNP 100_CD was_VBD
          added_VBN to_TO a_DT final_JJ concentration_NN of_IN 0_CD ._. 1_CD %_NN ,_, followed_VBN by_IN
          gentle_JJ mixing_VBG for_IN 30_CD min_NN at_IN 4_CD °_NN C_NNP ._. The_DT lysate_NN was_VBD clarified_VBN
          at_IN 12_CD ,_, 000_CD ×_NN g_SYM for_IN 10_CD min_NN at_IN 4_CD °_NN C_NNP ._. The_DT supernatant_NN was_VBD
          gently_RB mixed_VBN with_IN glutathione-sepharose_JJ beads_NNS
          (_( Amersham-_NNP Pharmacia_NNP )_) at_IN 4_CD °_NN C_NNP for_IN 30_CD min_NN ._. Beads_NNP containing_VBG
          GST_NNP proteins_NNS were_VBD collected_VBN by_IN low_JJ speed_NN centrifugation_NN ,_,
          followed_VBN by_IN three_CD successive_JJ washes_NNS with_IN PBS_NNP containing_VBG
          0_CD ._. 1_CD %_NN Triton_NNP X-_NNP 100_CD and_CC the_DT protease_NN inhibitors_NNS described_VBD
          above_IN ._.
          The_DT ELK-_NNP 1_CD ,_, ELK-_NNP 1_CD (_( 1_CD -_: 209_CD )_) ,_, ELK-_NNP 1_CD (_( 1_CD -_: 140_CD )_) ,_, and_CC
          ELK-_NNP 1_CD (_( 89_CD -_: 428_CD )_) proteins_NNS were_VBD transcribed_JJ and_CC translated_VBN in_IN
          vitro_NN using_VBG the_DT TNT_NNP T_NN 7_CD coupled_VBN reticulocyte_NN lysate_NN system_NN
          (_( Promega_NNP )_) according_VBG to_TO the_DT manufacture_NN 's_POS instructions_NNS ._.
          Translated_VBN proteins_NNS were_VBD radiolabeled_JJ with_IN the_DT EXPRE_NNP 35_CD S_NNP
          35_CD S_NNP protein_NN labeling_VBG mix_NN (_( Dupont_NNP NEN_NNP )_) ._. The_DT GST-pulldown_NNP
          assay_NN was_VBD done_VBN as_RB previously_RB described_VBD [_NN 22_CD ]_NN ._.
        
        
          Co-_NNP Immunoprecipitation_NNP
          COS-_NNP 7_CD cells_NNS were_VBD harvested_VBN in_IN PBS_NNP containing_VBG 0_CD ._. 1_CD mM_NN
          sodium_NN vanadate_NN and_CC collected_VBN by_IN low_JJ speed_NN
          centrifugation_NN ._. Cells_NNP were_VBD resuspended_JJ in_IN lysis_NNS buffer_NN
          (_( 10_CD mM_NN Tris_NNP (_( pH_NN 7_CD ._. 5_LS )_) ,_, 1_CD mM_NN EDTA_NNP ,_, 50_CD mM_NN NaCl_NNP ,_, 0_CD ._. 25_CD %_NN
          Nonidet_NNP P-_NNP 40_CD ,_, 1_CD mM_NN PMSF_NNP ,_, 1_CD mg_NN of_IN aprotinin_NN /_NN mL_NN ,_, 0_CD ._. 1_CD mM_NN
          sodium_NN vanadate_NN ,_, 10_CD mM_NN sodium_NN molybdate_NN ,_, and_CC 10_CD mM_NN
          β-glycerol_JJ phosphate_NN )_) and_CC lysed_JJ by_IN sonication_NN with_IN a_DT
          microtip_NN on_IN setting_VBG 2_CD and_CC 20_CD %_NN duty_NN cycle_NN for_IN 10_CD s_VBZ ._. After_IN
          clarification_NN by_IN centrifugation_NN at_IN 12_CD ,_, 000_CD ×_NN g_SYM for_IN 10_CD min_NN ,_,
          the_DT cell_NN extract_NN was_VBD incubated_JJ with_IN T_NN 7_CD tag_NN antibody_NN
          (_( Ab_NNP )_) -_: agarose_NN beads_NNS (_( Novagen_NNP )_) for_IN 2_CD h_NN ._. The_DT beads_NNS were_VBD
          collected_VBN by_IN low_JJ speed_NN centrifugation_NN and_CC washed_VBN 3_CD times_NNS
          with_IN lysis_NNS buffer_NN ._. All_DT steps_NNS were_VBD performed_VBN at_IN 4_CD °_NN C_NNP ._. After_IN
          washing_VBG ,_, the_DT beads_NNS were_VBD boiled_VBD for_IN 5_CD min_NN in_IN Laemmli_NNP
          sample_NN buffer_NN ._.
        
        
          Immunoblots_NNP
          The_DT samples_NNS from_IN the_DT coimmunoprecipitations_NNS described_VBD
          above_IN were_VBD analyzed_VBN by_IN electrophoresis_NNS on_IN an_DT SDS-_NNP 12_CD %_NN
          polyacrylamide_NN gel_NN for_IN 3_CD h_NN at_IN 160_CD V_NNP ._. The_DT gel_NN was_VBD
          equilibrated_JJ in_IN transfer_NN buffer_NN (_( 33_CD mM_NN Tris_NNP base_NN ,_, 192_CD mM_NN
          glycine_NN ,_, 20_CD %_NN methanol_NN )_) for_IN 15_CD min_NN before_IN transfer_NN of_IN
          proteins_NNS to_TO Immobilon-_NNP P_NN membrane_NN (_( Millipore_NNP Corp_NNP ._. )_) ._. After_IN
          transfer_NN ,_, an_DT immunoblot_NN was_VBD performed_VBN as_IN described_VBN
          previously_RB [_NN 22_CD ]_NN ._. A_DT 1_CD :_: 2000_CD dilution_NN of_IN anti-_NN Elk-_NNP 1_CD Ab_NNP
          (_( Santa_NNP Cruz_NNP Biotechnology_NNP )_) and_CC a_DT 1_CD :_: 5000_CD dilution_NN of_IN goat_NN
          anti-rabbit_JJ secondary_JJ Ab_NNP (_( Roche_NNP Molecular_NNP Biochemicals_NNP )_)
          were_VBD used_VBN ._. The_DT secondary_JJ Ab_NNP was_VBD detected_VBN using_VBG
          SuperSignal_NNP Chemiluminescent_NNP Substrate_NNP (_( Pierce_NNP )_) ._.
        
      
      
        Abbreviations_NNP
        aa_NN ,_, amino_JJ acid_NN ;_: Ab_NNP ,_, antibody_NN ;_: bp_NN ,_, base_NN pair_NN ;_: CaPO_NNP 
        4_CD ,_, calcium_NN phosphate_NN ;_: C_NNP /_NN EBPβ_NNP ,_,
        CCAAT-enhancer_NNP binding_JJ protein-beta_JJ ;_: CAT_NNP ,_, chloramphenicol_NN
        acetyl_NN transferase_NN ;_: DMEM_NNP ,_, Dulbecco_NNP 's_POS Modified_NNP Eagle_NNP Medium_NNP ;_:
        GST_NNP ,_, glutathione-_NN S-_NNP transferase_NN ;_: MAPK_NNP ,_, mitogen_NN activated_VBN
        protein_NN kinase_NN ;_: PBS_NNP ,_, phosphate_NN buffered_JJ saline_NN ;_: PMSF_NNP ,_,
        phenylmethylsulfonyl_NN fluoride_NN ;_: SRE_NNP ,_, serum_NN response_NN element_NN ;_:
        SRF_NNP ,_, serum_NN response_NN factor_NN ;_: TCF_NNP ,_, ternary_JJ complex_JJ
        factor_NN ._.
      
    
  
